Ypsomed Holding AG header image

Ypsomed Holding AG

YPSN

Equity

ISIN CH0019396990 / Valor 1939699

SIX Swiss Exchange (2026-07-24)
CHF 382.40+0.31%

Ypsomed Holding AG
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

Ypsomed Holding AG is a Swiss company specializing in the development and production of injection and infusion systems for self-medication, primarily serving the pharmaceutical and biotechnology sectors. The company operates through two main divisions: Ypsomed Delivery Systems (YDS) and mylife Diabetescare. YDS provides a wide array of technologies and services designed to ensure reliable and user-friendly injection systems, catering to companies that develop and market injectable therapies. Meanwhile, the mylife Diabetescare brand offers a comprehensive range of products and services aimed at simplifying self-treatment for individuals with diabetes, enhancing their ability to manage their condition discreetly and effectively. Ypsomed's focus on innovation and user-centric design positions it as a key player in the medical technology industry, particularly in the field of self-administered drug delivery solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-12.2%1Y
49.1%3Y
163%5Y

Performance

33.8%1Y
32.2%3Y
31.7%5Y

Volatility

Market cap

6142 M

Market cap (USD)

Daily traded volume (Shares)

8,121

Daily traded volume (Shares)

1 day high/low

340 / 328

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.50
Khiem Tran
Switzerland, 02 Nov 2025
star star star star star
There is potential but it’s right now lagging.
Khiem Tran
Switzerland, 31 Oct 2025
star star star star star
Ypsomed is under Track because of the high potential innovation and R&D.

EQUITIES OF THE SAME SECTOR

Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%SEK 276.30
Aster DM Healthcare Ltd.
Aster DM Healthcare Ltd. Aster DM Healthcare Ltd. Valor: 40341147
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%INR 784.00
Bruker Corp
Bruker Corp Bruker Corp Valor: 1635622
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.74%USD 60.45
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%SEK 85.20
Interparfums
Interparfums Interparfums Valor: 86977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 23.50
Elekta AB
Elekta AB Elekta AB Valor: 613625
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.84%SEK 47.00
Sanofi SA
Sanofi SA Sanofi SA Valor: 699381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%EUR 76.03
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.39%USD 5.98
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.85%SEK 309.40
ImmunityBio Inc
ImmunityBio Inc ImmunityBio Inc Valor: 110468647
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.05%USD 7.10